Comparative Study of the Efficacy and Safety of BCD-132 With Teriflunomide and Placebo in Multiple Sclerosis
Clinical trial NCT04056897 · COMPLETED
Trial details
- NCT number
- NCT04056897
- Sponsor
- Biocad
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-07
- Primary completion
- 2020-07-13
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.